Detalhe da pesquisa
1.
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
Clin Infect Dis
; 77(7): 950-960, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338118
2.
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
Lancet
; 400(10369): 2193-2196, 2022 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209762
3.
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Cancer Cell
; 41(5): 821-823, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116490
4.
SARS-CoV-2 mucosal neutralising immunity after vaccination.
Lancet Infect Dis
; 24(1): e4-e5, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070528
5.
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.
Lancet Infect Dis
; 23(7): 781-784, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290472